Kasparas12 (Talk | contribs) |
|||
(10 intermediate revisions by 4 users not shown) | |||
Line 23: | Line 23: | ||
<div class="modal-close"></div> | <div class="modal-close"></div> | ||
<div class="modal-content"> | <div class="modal-content"> | ||
− | <p><strong>Fig. 1</strong> Schematic overview of the SynDrop</p> | + | |
+ | <img style='max-width:100%' src='https://static.igem.org/mediawiki/2018/f/f7/T--Vilnius-Lithuania--DESCRIPTION_2_FIGURE.png'> | ||
+ | <p><strong>Fig. 1</strong> Fig. 1. Schematic overview of the SynDrop. Using microfluidic technology, we synthesize liposomes at a high throughput within which we encapsulate an in vitro transcription/translation system with DNA encoding a target membrane protein. In addition we encapsulate purified cellular membrane protein machinery and chaperones - they facilitate the insertion of synthesized target membrane proteins into the membrane. The system is also capable of displaying small molecules on the surface of the liposome, which makes SynDrop applicable for a novel liposome surface-display method. | ||
+ | </p> | ||
<p></p> | <p></p> | ||
<h2><var>“What I cannot create, I do not understand”</var></h2> | <h2><var>“What I cannot create, I do not understand”</var></h2> | ||
<h6>R. Feynmann, February 1988</h6> | <h6>R. Feynmann, February 1988</h6> | ||
<p></p> | <p></p> | ||
− | <p><h2>Brief overview of the SynDrop - Synthetic Droplets for Membrane Protein Research.</h2></p> | + | <p><h2 style="color: #61afaa; font-size:1.8em">Brief overview of the SynDrop - Synthetic Droplets for Membrane Protein Research.</h2></p> |
<p></p> | <p></p> | ||
<p> | <p> | ||
Line 41: | Line 44: | ||
</p> | </p> | ||
<p> | <p> | ||
− | However designing complex, several layered circuitries resembling the behavior of a natural cell is still an overwhelming challenge due to many limitations like crosstalk, mutations, ambiguous intracellular and extracellular conditions, and biological noise. Therefore we propose to start from something simpler and more minimal.. Although the journey of creating a synthetic minimal cell has already begun, we hoped to contribute to this ultimate goal as well by investing our time and effort. This year we are engineering liposomes, lipid-coated vesicles, that are perfect models to study the initial steps for creating synthetic cells. Liposomes can offer a system with fully controllable experimental parameters and only the exact elements for our custom circuit design without the need to ever worry about the crosstalk and noise. We believe that most of the future synthetic biology | + | However designing complex, several layered circuitries resembling the behavior of a natural cell is still an overwhelming challenge due to many limitations like crosstalk, mutations, ambiguous intracellular and extracellular conditions, and biological noise. Therefore we propose to start from something simpler and more minimal.. Although the journey of creating a synthetic minimal cell has already begun, we hoped to contribute to this ultimate goal as well by investing our time and effort. This year we are engineering liposomes, lipid-coated vesicles, that are perfect models to study the initial steps for creating synthetic cells. Liposomes can offer a system with fully controllable experimental parameters and only the exact elements for our custom circuit design without the need to ever worry about the crosstalk and noise. We believe that most of the future synthetic biology a |
+ | pplications will rely on bottom-up engineering solutions. Having mastered some hard-core bottom-up liposome engineering, we won’t take long to create the first synthetic cell. | ||
</p> | </p> | ||
<p> | <p> | ||
Line 60: | Line 64: | ||
<p></p> | <p></p> | ||
<h1>Applications</h1> | <h1>Applications</h1> | ||
+ | <img style='max-width:100%' src='https://static.igem.org/mediawiki/2018/e/eb/T--Vilnius-Lithuania--Bendra_apl.png'/> | ||
<p></p> | <p></p> | ||
<p>As our project focuses on a novel platform for membrane protein research it offers various future applications. | <p>As our project focuses on a novel platform for membrane protein research it offers various future applications. | ||
Line 93: | Line 98: | ||
<p></p> | <p></p> | ||
<h2>Phage display</h2> | <h2>Phage display</h2> | ||
− | <p> | + | |
+ | |||
+ | |||
+ | <p> <div class="image-container"> | ||
+ | <img src="https://static.igem.org/mediawiki/2018/e/ed/T--Vilnius-Lithuania--1_DisplaySys_phage.png"/> | ||
+ | </div></p> | ||
<table class="c65"> | <table class="c65"> | ||
<tbody> | <tbody> | ||
Line 101: | Line 111: | ||
</td> | </td> | ||
<td class="c43" colspan="1" rowspan="1"> | <td class="c43" colspan="1" rowspan="1"> | ||
− | <p class="c7"><span class="c17">10</span><span class="c17 c31">7</span></p> | + | <p class="c7"><span class="c17">10</span><span class="c17 c31"><sup>7</sup></span></p> |
</td> | </td> | ||
</tr> | </tr> | ||
Line 203: | Line 213: | ||
<li class="c34"><span class="c2">The low display rate can be a drawback. In the first round of panning where very few binders are to be enriched from a huge excess of unwanted phages, phages that are mostly “bald” can reduce the accessible molecular diversity of the library and the efficiency of the system</span></li> | <li class="c34"><span class="c2">The low display rate can be a drawback. In the first round of panning where very few binders are to be enriched from a huge excess of unwanted phages, phages that are mostly “bald” can reduce the accessible molecular diversity of the library and the efficiency of the system</span></li> | ||
<li class="c34"><span class="c2">If selection is done on cells, non specific phage binding is observed, due to phage protein interaction with cell membrane proteins </span></li> | <li class="c34"><span class="c2">If selection is done on cells, non specific phage binding is observed, due to phage protein interaction with cell membrane proteins </span></li> | ||
− | <li class="c62"><span class="c17">In phage display, libraries must be transformed into bacteria, limiting the number of possible independent sequences to 10</span><span class="c17 c31">9</span><span class="c17">–10</span><span class="c17 c31">10</span></li> | + | <li class="c62"><span class="c17">In phage display, libraries must be transformed into bacteria, limiting the number of possible independent sequences to 10</span><span class="c17 c31"><sup>9</sup></span><span class="c17">–10</span><span class="c17 c31"><sup>10</sup></span></li> |
</ul> | </ul> | ||
</td> | </td> | ||
Line 228: | Line 238: | ||
</table> | </table> | ||
<p></p> | <p></p> | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
<h2>Ribosome Display</h2> | <h2>Ribosome Display</h2> | ||
− | <p> | + | |
+ | |||
+ | <p><div class="image-container"> | ||
+ | <img src="https://static.igem.org/mediawiki/2018/f/fb/T--Vilnius-Lithuania--2_DisplaySys_ribosome.png"/> | ||
+ | </div></p> | ||
<table class="c65"> | <table class="c65"> | ||
<tbody> | <tbody> | ||
Line 237: | Line 256: | ||
</td> | </td> | ||
<td class="c0" colspan="1" rowspan="1"> | <td class="c0" colspan="1" rowspan="1"> | ||
− | <p class="c7"><span class="c17">10</span><span class="c17 c31">13-14</span></p> | + | <p class="c7"><span class="c17">10</span><span class="c17 c31"><sup>13-14</sup></span></p> |
</td> | </td> | ||
</tr> | </tr> | ||
Line 261: | Line 280: | ||
</td> | </td> | ||
<td class="c0" colspan="1" rowspan="1"> | <td class="c0" colspan="1" rowspan="1"> | ||
− | <p class="c12"><span class="c17">High affinity binders can be generated after 1</span><span class="c17 c31">st </span><span class="c2">round of selection, but most of the time, multiple rounds are done</span></p> | + | <p class="c12"><span class="c17">High affinity binders can be generated after 1</span><span class="c17 c31"><sup>st</sup> </span><span class="c2">round of selection, but most of the time, multiple rounds are done</span></p> |
</td> | </td> | ||
</tr> | </tr> | ||
Line 301: | Line 320: | ||
</td> | </td> | ||
<td class="c0" colspan="1" rowspan="1"> | <td class="c0" colspan="1" rowspan="1"> | ||
− | <p class="c7"><span class="c17">Stable in Mg</span><span class="c17 c31">2+</span></p> | + | <p class="c7"><span class="c17">Stable in Mg</span><span class="c17 c31"><sup>2+</sup></span></p> |
</td> | </td> | ||
</tr> | </tr> | ||
Line 318: | Line 337: | ||
<td class="c0" colspan="1" rowspan="1"> | <td class="c0" colspan="1" rowspan="1"> | ||
<ul class="c20 lst-kix_8k5bwrjmi1qe-0 start"> | <ul class="c20 lst-kix_8k5bwrjmi1qe-0 start"> | ||
− | <li class="c34"><span class="c17">Fast generation of big library as the complex is stabilized by Mg</span><span class="c17 c31">2+ </span><span class="c2">and can be readily dissociated by the addition of EDTA</span></li> | + | <li class="c34"><span class="c17">Fast generation of big library as the complex is stabilized by Mg</span><span class="c17 c31"><sup>2+</sup> </span><span class="c2">and can be readily dissociated by the addition of EDTA</span></li> |
− | <li class="c34"><span class="c17">A significant advantage of </span><span class="c5">in vitro</span><span class="c2"> translation methods is the ability to modify the genetic code to allow the incorporation of non-canonical, unnatural amino acids, to give molecules with novel properties, such as cyclic peptides with increased serum, stability </span></li> | + | <li class="c34"><span class="c17">A significant advantage of </span><span class="c5"><var>in vitro</var></span><span class="c2"> translation methods is the ability to modify the genetic code to allow the incorporation of non-canonical, unnatural amino acids, to give molecules with novel properties, such as cyclic peptides with increased serum, stability </span></li> |
<li class="c62"><span class="c2">Rapid isolation and direct evolution of high-affinity functional proteins, particularly antibodies</span></li> | <li class="c62"><span class="c2">Rapid isolation and direct evolution of high-affinity functional proteins, particularly antibodies</span></li> | ||
</ul> | </ul> | ||
Line 356: | Line 375: | ||
</table> | </table> | ||
<p></p> | <p></p> | ||
+ | |||
+ | |||
+ | |||
+ | |||
<h2>Cis-Activity (Cis) Display</h2> | <h2>Cis-Activity (Cis) Display</h2> | ||
− | <p> | + | |
+ | <p><div class="image-container"> | ||
+ | <img src="https://static.igem.org/mediawiki/2018/7/71/T--Vilnius-Lithuania--3_DisplaySys_CIS.png"/> | ||
+ | </div></p> | ||
<table class="c65"> | <table class="c65"> | ||
<tbody> | <tbody> | ||
Line 365: | Line 391: | ||
</td> | </td> | ||
<td class="c21" colspan="1" rowspan="1"> | <td class="c21" colspan="1" rowspan="1"> | ||
− | <p class="c7"><span class="c17">10</span><span class="c17 c31">10</span></p> | + | <p class="c7"><span class="c17">10</span><span class="c17 c31"><sup>10</sup></span></p> |
</td> | </td> | ||
</tr> | </tr> | ||
Line 457: | Line 483: | ||
</table> | </table> | ||
<p></p> | <p></p> | ||
+ | |||
+ | |||
<h2>mRNA Display</h2> | <h2>mRNA Display</h2> | ||
− | <p> | + | |
− | + | <p><div class="image-container"> | |
+ | <img src="https://static.igem.org/mediawiki/2018/f/f1/T--Vilnius-Lithuania--4_DisplaySys_mRNA.png"/> | ||
+ | </div></p> | ||
+ | |||
+ | <table class="c65"> | ||
<tbody> | <tbody> | ||
<tr class="c1"> | <tr class="c1"> | ||
Line 466: | Line 498: | ||
</td> | </td> | ||
<td class="c39" colspan="1" rowspan="1"> | <td class="c39" colspan="1" rowspan="1"> | ||
− | <p class="c7"><span class="c17">10</span><span class="c17 c31">14 </span></p> | + | <p class="c7"><span class="c17">10</span><span class="c17 c31"><sup>14</sup> </span></p> |
</td> | </td> | ||
</tr> | </tr> | ||
Line 586: | Line 618: | ||
</table> | </table> | ||
<p></p> | <p></p> | ||
+ | |||
<h2>Covalent Antibody Display</h2> | <h2>Covalent Antibody Display</h2> | ||
− | <p> | + | <p><div class="image-container"> |
+ | <img src="https://static.igem.org/mediawiki/2018/1/1c/T--Vilnius-Lithuania--5_DisplaySys_CAD.png"/> | ||
+ | </div></p> | ||
+ | |||
+ | |||
<table class="c65"> | <table class="c65"> | ||
<tbody> | <tbody> | ||
Line 595: | Line 632: | ||
</td> | </td> | ||
<td class="c21" colspan="1" rowspan="1"> | <td class="c21" colspan="1" rowspan="1"> | ||
− | <p class="c7"><span class="c17">10</span><span class="c17 c31">7</span></p> | + | <p class="c7"><span class="c17">10</span><span class="c17 c31"><sup>7</sup></span></p> |
</td> | </td> | ||
</tr> | </tr> | ||
Line 708: | Line 745: | ||
</table> | </table> | ||
<p></p> | <p></p> | ||
+ | |||
+ | |||
<h2>Yeast Explay</h2> | <h2>Yeast Explay</h2> | ||
− | <p> | + | |
+ | <p><div class="image-container"> | ||
+ | <img src="https://static.igem.org/mediawiki/2018/4/42/T--Vilnius-Lithuania--6_DisplaySys_Yeast.png"/> | ||
+ | </div></p> | ||
+ | |||
<table class="c65"> | <table class="c65"> | ||
<tbody> | <tbody> | ||
Line 717: | Line 760: | ||
</td> | </td> | ||
<td class="c21" colspan="1" rowspan="1"> | <td class="c21" colspan="1" rowspan="1"> | ||
− | <p class="c7"><span class="c17">Up to 10</span><span class="c17 c31">14</span></p> | + | <p class="c7"><span class="c17">Up to 10</span><span class="c17 c31"><sup>14</sup></span></p> |
</td> | </td> | ||
</tr> | </tr> | ||
Line 819: | Line 862: | ||
</table> | </table> | ||
<p></p> | <p></p> | ||
+ | |||
+ | |||
<h2>Eukaryotic Display</h2> | <h2>Eukaryotic Display</h2> | ||
− | <p> | + | |
+ | <p><div class="image-container"> | ||
+ | <img src="https://static.igem.org/mediawiki/2018/1/12/T--Vilnius-Lithuania--7_DisplaySys_Eukaryotic.png"/> | ||
+ | </div></p> | ||
<table class="c65"> | <table class="c65"> | ||
<tbody> | <tbody> | ||
Line 828: | Line 876: | ||
</td> | </td> | ||
<td class="c30" colspan="1" rowspan="1"> | <td class="c30" colspan="1" rowspan="1"> | ||
− | <p class="c7"><span class="c17">10</span><span class="c17 c31">7</span></p> | + | <p class="c7"><span class="c17">10</span><span class="c17 c31"><sup>7</sup></span></p> |
</td> | </td> | ||
</tr> | </tr> | ||
Line 924: | Line 972: | ||
</table> | </table> | ||
<p></p> | <p></p> | ||
+ | |||
+ | |||
<h2>Water-In-Oil Emulsions</h2> | <h2>Water-In-Oil Emulsions</h2> | ||
− | <p> | + | <p><div class="image-container"> |
+ | <img src="https://static.igem.org/mediawiki/2018/f/fb/T--Vilnius-Lithuania--8_DisplaySys_Water_in_oil.png"/> | ||
+ | </div></p> | ||
<table class="c65"> | <table class="c65"> | ||
<tbody> | <tbody> | ||
Line 933: | Line 985: | ||
</td> | </td> | ||
<td class="c30" colspan="1" rowspan="1"> | <td class="c30" colspan="1" rowspan="1"> | ||
− | <p class="c7"><span class="c17 c51">10</span><span class="c17 c51 c31">10</span></p> | + | <p class="c7"><span class="c17 c51">10</span><span class="c17 c51 c31"><sup>10</sup></span></p> |
</td> | </td> | ||
</tr> | </tr> | ||
Line 1,049: | Line 1,101: | ||
</table> | </table> | ||
<p></p> | <p></p> | ||
− | <h2>Liposome | + | <h2>Liposome Display</h2> |
− | <p> | + | |
+ | |||
+ | <p><div class="image-container"> | ||
+ | <img src="https://static.igem.org/mediawiki/2018/a/a8/T--Vilnius-Lithuania--9_DisplaySys_Liposome.png"/> | ||
+ | </div></p> | ||
<table class="c65"> | <table class="c65"> | ||
<tbody> | <tbody> | ||
Line 1,058: | Line 1,114: | ||
</td> | </td> | ||
<td class="c13" colspan="1" rowspan="1"> | <td class="c13" colspan="1" rowspan="1"> | ||
− | <p class="c7"><span class="c17">10</span><span class="c17 c31">7</span></p> | + | <p class="c7"><span class="c17">10</span><span class="c17 c31"><sup>7</sup></span></p> |
</td> | </td> | ||
</tr> | </tr> |
Latest revision as of 20:41, 4 November 2018
Description
Describe the Impossible
Cell-free systems are becoming an increasingly popular in vitro tool to study biological processes as it is accompanied by less intrinsic and extrinsic noise. Relying on fundamental concepts of synthetic biology, we apply a bottom-up forward engineering approach to create a novel cell-free system for unorthodox protein-evolution. The core of this system is cell-sized liposomes that serve as excellent artificial membrane models. By encapsulating genetic material and full in vitro protein transcription and translation systems within the liposomes, we create reliable and incredibly efficient nanofactories for the production of target proteins. Even though there are many alternative proteins that can be synthesized, our main focus is directed towards membrane proteins, which occupy approximately one third of living-cells’ genomes. Considering their significance, membrane proteins are spectacularly understudied since synthesis and thus characterization of them remain prevailing obstacles to this day. We aim to utilize liposomes as nanofactories for directed evolution of membrane proteins. Furthermore, by means of directed membrane protein-evolution, a universal exposition system will be designed in order to display any protein of interest on the surface of the liposome. This way, a system is built where a phenotype of a particular protein is expressed on the outside while containing its genotype within the liposome. To prove the concept, small antibody fragments will be displayed to create a single-chain variable fragment (scFv) library for rapid screening of any designated target.